This article is available to subscribers. Subscribe now. Already have an account? Sign in

Original ArticleFree PreviewArchive

Familial Hyperglucagonemia — An Autosomal Dominant Disorder

List of authors.
  • Guenther Boden, M.D.,
  • and Oliver E. Owen, M.D.

Abstract

Basal Immunoreactive glucagon was elevated in four of nine asymptomatic relatives of a patient with glucagonoma. Immunoreactive glucagon remained elevated throughout 22 to 25 hours of continuous observation. Glucagon responses to intravenous glucose and arginine or mixed meals (or both) were abnormal, whereas glucose and insulin responses were normal. Gel filtration of plasma revealed that over 85 per cent of the four relatives' immunoreactive glucagon had a molecular weight of >9000 daltons whereas that of 70 per cent of the patients with glucagonoma had a molecular weight of 3500 daltons, with the remainder eluting in the area of 9000 daltons. Pancreatic angiograms and hepatic scintiscans were normal in all four relatives. The data suggest an autosomal dominant transmission of hyperglucagonemia in this family. Immunoreactive glucagon with a molecular weight of 3500 or 9000 daltons appears to be required for the development of the clinical glucagonoma syndrome. (N Engl J Med 296:534–538, 1977

Funding and Disclosures

Supported by grants (1 RO1 AM 16348–03, AM Ca 19397–01, AM 1610203 and 5 MO1 RR 349–10) from the National Institutes of Health, General Clinical Research Centers Branch.

We are indebted to Mrs. P. James for technical assistance, to Mrs. R. Matza for assistance and to the nursing staff of the General Clinical Research Center for nursing care.

Author Affiliations

From the Department of Medicine and the General Clinical Research Center, Temple University Health Sciences Center (address reprint requests to Dr. Boden at Temple University Hospital, 3401 N. Broad St., Philadelphia, PA 19140).

Print Subscriber? Activate your online access.